Cargando…

Invasion and metastasis in pancreatic cancer

Pancreatic cancer remains a challenging disease with an overall cumulative 5-year survival rate below 1%. The process of cancer initiation, progression and metastasis is still not understood well. Invasion and tumor metastasis are closely related and both occur within a tumour-host microecology, whe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keleg, Shereen, Büchler, Peter, Ludwig, Roman, Büchler, Markus W, Friess, Helmut
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC149416/ https://www.ncbi.nlm.nih.gov/pubmed/12605717 http://dx.doi.org/10.1186/1476-4598-2-14

Ejemplares similares

New molecular aspects in pathogenesis and progression of pancreatic cancer
por: Büchler, Peter, et al.
Publicado: (2003)

Splenic and portal vein thrombosis in pancreatic metastasis from Renal cell carcinoma
por: Shrikhande, Shailesh V, et al.
Publicado: (2006)

BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion
por: Kayed, Hany, et al.
Publicado: (2007)

Pancreatic metastasis from gastric carcinoma: a case report
por: Wente, Moritz N, et al.
Publicado: (2004)

A proposal for a new clinical classification of chronic pancreatitis
por: Büchler, Markus W, et al.
Publicado: (2009)

Melanoma Inhibitory Activity (MIA) increases the invasiveness of pancreatic cancer cells
por: El Fitori, Jamael, et al.
Publicado: (2005)

Pancreatic metastasis of Merkel cell carcinoma and concomitant insulinoma: Case report and literature review
por: Bachmann, Jeannine, et al.
Publicado: (2005)

Effects of STI571 (gleevec) on pancreatic cancer cell growth
por: Li, Junsheng, et al.
Publicado: (2003)

Prognostic Significance of Erythropoietin in Pancreatic Adenocarcinoma
por: Welsch, Thilo, et al.
Publicado: (2011)

Corticosteroid co-treatment induces resistance to chemotherapy in surgical resections, xenografts and established cell lines of pancreatic cancer
por: Zhang, Chengwen, et al.
Publicado: (2006)

Current State of Surgical Management of Pancreatic Cancer
por: Hackert, Thilo, et al.
Publicado: (2011)

Current State of Vascular Resections in Pancreatic Cancer Surgery
por: Hackert, Thilo, et al.
Publicado: (2015)

Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer
por: Li, Junsheng, et al.
Publicado: (2005)

Pancreatic cancerrelated cachexia: influence on metabolism and correlation to weight loss and pulmonary function
por: Bachmann, Jeannine, et al.
Publicado: (2009)

Local radicality and survival outcome of pancreatic cancer surgery
por: Niesen, Willem, et al.
Publicado: (2019)

Second-Look Operation for Unresectable Pancreatic Ductal Adenocarcinoma at a High-Volume Center
por: Michalski, Christoph W., et al.
Publicado: (2007)

Autoimmune Pancreatocholangitis, Non-Autoimmune Pancreatitis and Primary Sclerosing Cholangitis: A Comparative Morphological and Immunological Analysis
por: Esposito, Irene, et al.
Publicado: (2008)

Neural Invasion in Pancreatic Cancer: The Past, Present and Future
por: Demir, Ihsan Ekin, et al.
Publicado: (2010)

Duodenum preserving pancreatectomy in chronic pancreatitis: Design of a randomized controlled trial comparing two surgical techniques [ISRCTN50638764]
por: Köninger, Jörg, et al.
Publicado: (2006)

Regulation and functional role of the Runt-related transcription factor-2 in pancreatic cancer
por: Kayed, H, et al.
Publicado: (2007)

Refining the Treatment of Pancreatic Cancer From Big Data to Improved Individual Survival
por: Bailey, Peter, et al.
Publicado: (2023)

The impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy?
por: D’Haese, Jan G, et al.
Publicado: (2013)

Surgical Treatment of Necrotizing Pancreatitis
por: Uhl, W., et al.
Publicado: (1997)

PHD3 regulates differentiation, tumour growth and angiogenesis in pancreatic cancer
por: Su, Y, et al.
Publicado: (2010)

Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma.
por: Cantero, D., et al.
Publicado: (1997)

Severe acute pancreatitis: surgical indications and treatment
por: Heckler, Max, et al.
Publicado: (2020)

BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation
por: Hennig, R, et al.
Publicado: (2008)

The impact of hypoxia in pancreatic cancer invasion and metastasis
por: Yuen, Angela, et al.
Publicado: (2014)

Surgical Approaches to Chronic Pancreatitis
por: Hartmann, Daniel, et al.
Publicado: (2015)

Prognostic relevance of the revised R status definition in pancreatic cancer: meta-analysis
por: Leonhardt, Carl Stephan, et al.
Publicado: (2022)

Neurotensin receptors in pancreatic ductal carcinomas
por: Körner, Meike, et al.
Publicado: (2015)

Combining forces to hit cancer stem cells: TRAIL-lymphocytes and EpCAMxCD3 bispecific antibody show efficacy against pancreatic cancer
por: Herr, Ingrid, et al.
Publicado: (2012)

VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma
por: Beckermann, B M, et al.
Publicado: (2008)

Pancreatic cancer: disease dynamics, tumor biology and the role of the microenvironment
por: Ansari, Daniel, et al.
Publicado: (2018)

Ampullary adenocarcinoma – differentiation matters
por: Schirmacher, Peter, et al.
Publicado: (2008)

AB0 blood group and prognosis in patients with pancreatic cancer
por: Rahbari, Nuh N, et al.
Publicado: (2012)

Palliative Interventional and Surgical Therapy for Unresectable Pancreatic Cancer
por: Assfalg, Volker, et al.
Publicado: (2011)

Main- and Branch-Duct Intraductal Papillary Mucinous Neoplasms: Extent of Surgical Resection
por: Hackert, Thilo, et al.
Publicado: (2015)

Adjuvant gemcitabine after resection of pancreatic cancer without significant difference in overall survival: a retrospective cohort study
por: Bauer, Katrin, et al.
Publicado: (2023)

Pancreatic cancer — lessons from the past decade
por: Demir, Ihsan Ekin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7us74g64c6evj8urco1bscc7e7